Peter Hersey
University of Sydney(AU)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Cutaneous Melanoma Detection and Management
Most-Cited Works
- → Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma(2013)3,383 cited
- → Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib(2012)2,141 cited
- → Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma(2012)2,130 cited
- → Whole-genome landscapes of major melanoma subtypes(2017)1,452 cited
- → Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma(2017)1,368 cited
- → Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group(2012)1,342 cited
- → Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma